Newron announces US initiation of its ENIGMA-TRS 2 Phase III global study of evenamide for patients with treatment-resistant ...

Newron Pharmaceuticals SpA ( ($CH:NWRN) ) just unveiled an announcement. Newron Pharmaceuticals has announced the US launch of its global Phase ...

Specialized brain scans may accurately predict whether a psychotic patient will go on to develop treatment-resistant schizophrenia, Dutch researchers report. The scan -- called a ...

Lucid Capital analyst Elemer Piros initiated coverage of Newron Pharma (NWPHF) with a Buy rating and CHF 73 price target The ...

Please provide your email address to receive an email when new articles are posted on . Evenamide was associated with clinically significant improvements in treatment-resistant schizophrenia at 6 ...

Newron Pharmaceuticals (SWX:NWRN) just kicked off its ENIGMA TRS 2 Phase III trial in the US, a key late stage step for Evenamide in treatment resistant schizophrenia after securing FDA and IRB ...

Medication management of patients on clozapine is impacted when individuals start or stop cigarette smoking. A reduction in cigarette smoking or smoking cessation increases clozapine plasma ...

The Psychiatry and Mental Health research group at the Germans Trias i Pujol Research Institute (IGTP), together with the ETEP (Study and Treatment of Psychotic Episodes) group at Hospital del Mar, ...

I remember the first time I heard the time "treatment resistant." It was from a friend as they shared with me their mental health story. As this conversation took place some years before my schooling ...

A woman on clozapine develops severe gastrointestinal hypomotility that progresses to toxic megacolon and multiorgan failure, ...